Curaleaf (CURLF) stock has surged 80% year to date and 230% over the past three months. With a market cap of $1.7 billion, Curaleaf operates one of the largest U.S. dispensary networks and offers a wide range of cannabis products. The company is focusing on profitability and expanding its product reach.

Curaleaf is expanding its distribution channels for branded products and opening new stores. Internationally, the company is preparing for launches in key markets, aiming to increase revenue. Despite positive Q2 earnings, Curaleaf still reported a net loss, showing the need for continued growth and stabilization.

Analysts have a “Moderate Buy” rating on CURLF stock, with a 12-month average target price of $3, indicating over 13% upside potential. While the company is making progress with margins and cash flow, high leverage and ongoing losses pose risks to investors.

Read more at Yahoo Finance: This Red-Hot Cannabis Stock Has Nearly Doubled in 2025. Should You Buy It Here?